PepGen (PEPG) Change in Accured Expenses (2021 - 2026)
PepGen (PEPG) posted Change in Accured Expenses of -$3.5 million for Q1 2026, down 1482.75% sequentially from $255000.0 in Q4 2025, and down 230.06% YoY from $2.7 million in Q1 2025.
PepGen (PEPG) Change in Accured Expenses (2021 - 2026) Analysis & Trends
PepGen has reported Change in Accured Expenses for 6 years, with the latest figure at -$3.5 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 230.06% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.5 million (down 221.66% YoY) and the FY2025 annual result came in at -$3.3 million, down 96.51% from the prior year.
- Change in Accured Expenses slipped to -$3.5 million in Q1 2026 per PEPG's latest filing, from $255000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $6.5 million in Q1 2022 and troughed at -$6.8 million in Q1 2024.
- A 5-year average of -$88470.6 and a median of $166000.0 in 2023 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 829.66% in 2024, down 4175.3% in 2024.
- Over 5 years, Change in Accured Expenses stood at $2.1 million in 2022, then slumped by 127.42% to -$563000.0 in 2023, then soared by 825.93% to $4.1 million in 2024, then tumbled by 93.76% to $255000.0 in 2025, then sank by 1482.75% to -$3.5 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$3.5 million, $255000.0, and -$4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | PepGen | 207.09 Mn | 207.09 Mn | - | -465,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -465,000.00 |
| Jun 30, 2026 | -465,000.00 |
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | -4.02 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.50 Mn |
| Mar 31, 2024 | -6.77 Mn |
| Mar 31, 2024 | -6.77 Mn |